Michael Johnson, President of the New Jersey Innovation Institute, presents a clear case for accelerating health innovation through a venture studio model, with Tom Jones, Managing Partner at FINN Partners, hosting the session and framing the strategic context. Johnson positions NJII as a practical bridge between academic research and the outside world, built to make university capabilities usable for industry and government partners. He distinguishes venture studios from traditional startups, accelerators, and corporate venture capital by emphasizing company creation around a validated problem and an identified first customer. The presentation highlights what makes the model credible in practice, including structural independence, experienced entrepreneurial operators, sufficient runway, and real back office support. Jones reinforces the central theme that collaboration aligns intellectual property, talent, and market demand into scalable execution.